SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AVIGEN(avgn)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom M who wrote (72)8/22/1997 3:23:00 AM
From: Czechsinthemail   of 228
 
Tom,

It is hard to believe this stock, particularly when you can buy it for around its cash value per share. Biotech has been a laggard and small caps, too, which has made AVGN something like an outcast from the leper colony. But recently the small caps have started to do relatively better than the larger cap companies. And sooner or later biotech is due to be recognized and will once again become hot.
Since we haven't heard much from the company, I'm hoping they may have saved some big announcements for their quarterly earnings announcement. I think any significant product or partnering news could really pop it to the upside. Meanwhile, it's hard to imagine much more downside. On balance a great risk/reward situation, but so far kind of sleep inducing.

Baird
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News